Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
35 Cards in this Set
- Front
- Back
Doctrine of Signatures
|
Original source of drug knowledge: characteristic appearance indicated function divinely preordained.
|
|
Antibiotic Sources
|
Derived from compounds found in bacteria and fungi. Natural: straight from producer w/o modification. Semisynthetic: modified after taken from producer. Synthetic: made in lab based on nature.
|
|
Antibiotic
|
A metabolic compound from one microorganism which intends to destroy or inhibit another microorganism.
|
|
Mechanisms of Drug Action
|
Disrupt cell walls, cell membranes, proteins, nucleic acids, or other.
|
|
Cell Wall Disruptive Drugs
|
Inhibit cell wall synthesis; target young cells actively building new cell walls, less effective with dormant/older cells.
|
|
Ways Drugs Disrupt Cell Walls
|
Inhibit transpeptidase from cross-linking (cephalosporin, penicillin), inhibit peptidoglycan subunit construction (cycloserine), inhibit elongation of peptidoglycan chains (vancomycin).
|
|
Cell Membrane Disruptive Drugs
|
Disrupt cell membrane integrity by disrupting phospholipid integrity (polymyxins), disrupting embedded molecules (amphitericin B & nystatin disrupt sterols), or prohibiting ergosterol production (azoles). Can harm human cells.
|
|
Protein Disruptive Drugs
|
Interfere with protein synthesis or function; human mitochondria have a bacterium-like ribosome and can be impacted.
|
|
Ways Drugs Disrupt Proteins
|
Inhibit protein synthesis initation (oxazolidones). Interfere w/ ribosome function. Inhibit tRNA docking (tetracycline). Interfere with associated enzymes (protease inhibitors). Interfere with proteins themselves.
|
|
Ribosome Function Interference
|
Bind to 30S subunit to result in misread mRNA (streptomycin) or disrupt proofreading/subunit sliding (aminoglycosides), bind to 50S subunit to prohibit peptide bonding between amino acids (chloramphenicol) or prevent protein detachment or mRNA translocation (erythromycin).
|
|
Protease Inhibitors
|
Inhibit the enzyme that cleaves polyproteins resulting in long, nonfunctional chains of proteins.
|
|
Nucleic Acid Disruptive Drugs
|
Interfere w/ nucleic acid itself by cross-linking the double-helix (chloroquine) or mimicking nucleotide (nucleotide analogues like AZT acyclovir, flucytosine); interfere with associated enzymes like gyrases (quinolones) or polymerases (rifamycins, non-nucleoside analogues).
|
|
Other Mechanisms of Drug Action
|
Interfere w/ virus entry (as Fuzeon blocks HIV), or entry and release both by disrupting H+ dynamics (amantadine) or neuraminidase activity.
|
|
Antiviral Drug Activity
|
Blocks adsorption (Amantidine, Fuzeon, Relenza, Tamiflu), blocks transcription/translation/replication (Acyclovir, AZT, nevirapine), prevent virion maturation (Saquinavir, Amantadine, Tamiflu).
|
|
Interferon
|
Produced by leukocytes and fibroblasts; alpha, beta, or gamma; antiviral and anticancer properties.
|
|
Interferon Functions
|
Reduce healing time and side effects of viral infection, reduce symptoms of acute and chronic viral infection, slow cancer progress.
|
|
Interferon Activity
|
Hijacked cell can warn surrounding cells by producing interferons, and all cells induce resistance. Early step used by immune system.
|
|
Antibacterial Drugs 1
|
Beta-lactam compounds, aminoglycosides, and tetracyclines.
|
|
Beta-lactam Compounds
|
Penicillin & cephalosporin groups.
|
|
Aminoglycosides
|
Gentamicin and streptomycin.
|
|
Tetracyclines
|
Aureomycin, tetracyline, doxcycline (both natural & synthetics).
|
|
Antibacterial Drugs 2
|
Chloramphenicol, -mycin, bacitracin and polymyxin; synthetics & derivatives of these include Sulfa drugs, sulfones, trimethoprim, & oxazolidones.
|
|
Antifungal Drugs
|
Often have side effects on humans. Macrolide polyenes (amphotericin B and nystatin), griseofulvin, azoles, flucytosine.
|
|
Griseofulvin
|
Interferes with mitosis by disrupting spindle fibers.
|
|
Antiprotozoan / Antimetazoan Drugs
|
Protozoan malaria ("quin") and amoebas. Eukaryotic piperazine and pyrantel paralyze muscles.
|
|
Drug Resistance
|
Intrinsic (resistant to own products) or acquired (mutations and recombination - a medical concern).
|
|
R (resistance) Factors
|
Plasmids transferred mainly thru conjugation; also transduction or transformation.
|
|
Transposens
|
"Jumping genes" between chromosomes and plasmids; sometimes replicate.
|
|
Drug Resistance Evolution
|
Broad spectrum drugs and crowded conditions invite microbes to adapt.
|
|
Drug Resistance Mechanisms
|
Inactivate drug, decrease drug permeability, inc. drug elimination, change drug receptor, change metabolic pattern.
|
|
Drug Inactivation
|
Allow drug in and an enzyme acts on it, rendering it dysfunctional (ex. beta lactamases). Inherent or acquired.
|
|
Decreasing Drug Permeability
|
Change transport mechanism that lets drug in (ex. blocking penicillin entry)
|
|
Increasing Drug Elimination
|
Allow drug in and spit it back out via efflux pump - works against multiple drugs (ex. tetracycline resistance).
|
|
Changing Drug Receptor
|
Modify or shield drug target; change ribosome structure, protein structure, or target composition.
|
|
Changing Metabolic Pattern
|
Choose a different metabolic option or stop metabolic activity completely.
|